NATtrol Monkeypox Virus (Recombinant) Stock is formulated with purified, intact bacterial cells containing synthetic Monkeypox virus sequence which includes portions of the following gene regions: E9L, G2R, B2R and C3L. The cells have been chemically modified to render them noninfectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol Monkeypox Virus (Recombinant) Stock in a proprietary matrix.

NATtrol Monkeypox Virus (Recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of Monkeypox virus DNA. NATtrol Monkeypox Virus (Recombinant Stock enables laboratories to monitor test variation, lotto-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

PRE-ORDER TODAY!

+2? to +8? C.
Product Insert.pdf

Material Safety Data Sheet.pdf